Compounds > deferoxamine

deferoxamine and oligonucleotides

deferoxamine has been researched along with oligonucleotides in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's3 (60.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ganesh, KN; Joshi, RR1
Chen, SD; Hsu, CY; Ju, TC; Xu, JM; Yang, DI; Yang, YT1
Bartrons, R; Caro, J; Duran, J; Gómez, M; Kong, X; Navarro-Sabaté, A; Obach, M; Perales, JC; Rosa, JL; Ventura, F1
Hogenesch, JB; LaPres, JJ; Phillips, JM; Vengellur, A1
Irwin, DC; Loomis, Z; Maltzahn, J; Tarshis, S1

Other Studies

5 other study(ies) available for deferoxamine and oligonucleotides

ArticleYear
Duplex and triplex directed DNA cleavage by oligonucleotide-Cu(II)/Co(III) metallodesferal conjugates.
    Biochimica et biophysica acta, 1994, Dec-15, Volume: 1201, Issue:3

    Topics: Base Sequence; Deferoxamine; DNA; DNA Damage; Molecular Sequence Data; Oligonucleotides; Organometallic Compounds

1994
Carbamoylating chemoresistance induced by cobalt pretreatment in C6 glioma cells: putative roles of hypoxia-inducible factor-1.
    British journal of pharmacology, 2004, Volume: 141, Issue:6

    Topics: Animals; Antineoplastic Agents, Alkylating; Carmustine; Cell Line, Tumor; Cell Survival; Cobalt; Deferoxamine; DNA-Binding Proteins; Down-Regulation; Drug Resistance, Neoplasm; Glioblastoma; Glioma; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Iron Chelating Agents; Neuroprotective Agents; Nuclear Proteins; Oligonucleotides; Rats; Transcription Factors

2004
6-Phosphofructo-2-kinase (pfkfb3) gene promoter contains hypoxia-inducible factor-1 binding sites necessary for transactivation in response to hypoxia.
    The Journal of biological chemistry, 2004, Dec-17, Volume: 279, Issue:51

    Topics: Animals; Binding Sites; Biotinylation; Blotting, Western; Cell Hypoxia; Cell Line; Cell Proliferation; Cobalt; Deferoxamine; Enhancer Elements, Genetic; Fructosediphosphates; Gene Deletion; Gene Expression Regulation; Genes, Reporter; Glycine; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Iron Chelating Agents; Luciferases; Mice; Models, Genetic; Oligonucleotides; Oxygen; Phosphofructokinase-2; Plasmids; Promoter Regions, Genetic; Protein Binding; Protein Isoforms; Protein Structure, Tertiary; Proteins; Receptors, Estrogen; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Software; Time Factors; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transfection; Up-Regulation

2004
Gene expression profiling of hypoxia signaling in human hepatocellular carcinoma cells.
    Physiological genomics, 2005, Aug-11, Volume: 22, Issue:3

    Topics: Algorithms; Carcinoma, Hepatocellular; Cell Line, Tumor; Cobalt; Deferoxamine; DNA Primers; Down-Regulation; Erythrocytes; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Hypoxia; Liver Neoplasms; Nickel; Nucleic Acid Hybridization; Oligonucleotide Array Sequence Analysis; Oligonucleotides; Oxygen; Reverse Transcriptase Polymerase Chain Reaction; RNA; Signal Transduction; Transcription, Genetic; Up-Regulation

2005
Preventing High Altitude Cerebral Edema in Rats with Repurposed Anti-Angiogenesis Pharmacotherapy.
    Aerospace medicine and human performance, 2016, Dec-01, Volume: 87, Issue:12

    Topics: Acetazolamide; Altitude; Altitude Sickness; Angiogenesis Inducing Agents; Angiogenesis Inhibitors; Animals; Brain Edema; Capillary Permeability; Carbonic Anhydrase Inhibitors; Cerebral Arteries; Cerebral Veins; Deferoxamine; Indoles; Male; Niacinamide; Oligonucleotides; Rats; Rats, Sprague-Dawley

2016